Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1981 Dec;74(4):757P–988P.

Proceedings of the Fiftieth Anniversary Meeting of the British Pharmacological Society, University of Oxford, 16-18 September 1981. Abstracts.

PMCID: PMC2071899  PMID: 6118192

Full text

PDF
757P

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARIAS I. M. Ethereal and N-linked glucuronide formation by normal and Gunn rats in vitro and in vivo. Biochem Biophys Res Commun. 1961 Nov 1;6:81–84. doi: 10.1016/0006-291x(61)90388-6. [DOI] [PubMed] [Google Scholar]
  2. Adcock J. J., Garland L. G. A possible role for lipoxygenase products as regulators of airway smooth muscle reactivity. Br J Pharmacol. 1980 Jun;69(2):167–169. doi: 10.1111/j.1476-5381.1980.tb07886.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ahtee L. Inhibition by apomorphine of the metoclopramide-induced catalepsy and increase in striatal homovanillic acid content. Br J Pharmacol. 1975 Nov;55(3):381–385. doi: 10.1111/j.1476-5381.1975.tb06941.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Albert D. J., Chew G. L. The septal forebrain and the inhibitory modulation of attack and defense in the rat. A review. Behav Neural Biol. 1980 Dec;30(4):357–388. doi: 10.1016/s0163-1047(80)91247-9. [DOI] [PubMed] [Google Scholar]
  5. Anderson C., Stone T. W. On the mechanism of action of clonidine: effects on single central neurones. Br J Pharmacol. 1974 Jul;51(3):359–365. doi: 10.1111/j.1476-5381.1974.tb10670.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Apperley G. H., Coleman R. A., Kennedy I., Levy G. P. The cat isolated trachea, a useful preparation for the study of the smooth muscle relaxant action of prostaglandins [proceedings]. Br J Pharmacol. 1979 Nov;67(3):412P–413P. [PMC free article] [PubMed] [Google Scholar]
  7. Armfred T., Randrup A. Cholinergic mechanism in brain inhibiting amphetamine-induced stereotyped behaviour. Acta Pharmacol Toxicol (Copenh) 1968;26(4):384–394. doi: 10.1111/j.1600-0773.1968.tb00457.x. [DOI] [PubMed] [Google Scholar]
  8. Asch R. H., Fernandez E. O., Siler-Khodr T. M., Bartke A., Pauerstein C. J. Mechanism of induction of luteal phase defects by danazol. Am J Obstet Gynecol. 1980 Apr 1;136(7):932–940. doi: 10.1016/0002-9378(80)91054-6. [DOI] [PubMed] [Google Scholar]
  9. Atherton A., Born G. V. Quantitative investigations of the adhesiveness of circulating polymorphonuclear leucocytes to blood vessel walls. J Physiol. 1972 Apr;222(2):447–474. doi: 10.1113/jphysiol.1972.sp009808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Azmitia E. C., Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol. 1978 Jun 1;179(3):641–667. doi: 10.1002/cne.901790311. [DOI] [PubMed] [Google Scholar]
  11. Barbieri R. L., Osathanondh R., Canick J. A., Stillman R. J., Ryan K. J. Danazol inhibits human adrenal 21-and 11 beta-hydroxylation in vitro. Steroids. 1980 Mar;35(3):251–263. doi: 10.1016/0039-128x(80)90038-0. [DOI] [PubMed] [Google Scholar]
  12. Barkey R. J., Shani J., Lahav M., Amit T., Youdim M. B. Effect of prolactin and prostaglandins on the stimulation of prolactin binding sites in the male rat liver. Mol Cell Endocrinol. 1981 Feb;21(2):129–138. doi: 10.1016/0303-7207(81)90050-2. [DOI] [PubMed] [Google Scholar]
  13. Beani L., Bianchi C., Giacomelli A., Tamberi F. Noradrenaline inhibition of acetylcholine release from guinea-pig brain. Eur J Pharmacol. 1978 Mar 15;48(2):179–193. doi: 10.1016/0014-2999(78)90327-8. [DOI] [PubMed] [Google Scholar]
  14. Beresford R. A., Fastier F. N. Effects of some S-alkylthiouroniums and related compounds on the osmotic fragility and the membrane expansion of human erythrocytes. Br J Pharmacol. 1980;71(1):253–258. doi: 10.1111/j.1476-5381.1980.tb10933.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Bevan P., Bradshaw C. M., Szabadi E. The pharmacology of adrenergic neuronal responses in the cerebral cortex: evidence for excitatory alpha- and inhibitory beta-receptors. Br J Pharmacol. 1977 Apr;59(4):635–641. doi: 10.1111/j.1476-5381.1977.tb07732.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Blackwell G. J., Carnuccio R., Di Rosa M., Flower R. J., Parente L., Persico P. Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature. 1980 Sep 11;287(5778):147–149. doi: 10.1038/287147a0. [DOI] [PubMed] [Google Scholar]
  17. Blackwell G. J., Flower R. J., Russell-Smith N., Salmon J. A., Thorogood P. B., Vane J. R. Prostacyclin is produced in whole blood [proceedings]. Br J Pharmacol. 1978 Nov;64(3):436P–436P. [PMC free article] [PubMed] [Google Scholar]
  18. Bray M. A., Cunningham F. M., Ford-Hutchinson A. W., Smith M. J. Leukotriene B4: a mediator of vascular permeability. Br J Pharmacol. 1981 Mar;72(3):483–486. doi: 10.1111/j.1476-5381.1981.tb11000.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Brodie A. M., Schwarzel W. C., Shaikh A. A., Brodie H. J. The effect of an aromatase inhibitor, 4-hydroxy-4-androstene-3,17-dione, on estrogen-dependent processes in reproduction and breast cancer. Endocrinology. 1977 Jun;100(6):1684–1695. doi: 10.1210/endo-100-6-1684. [DOI] [PubMed] [Google Scholar]
  20. Brown D. A., Forward A., Marsh S. Antagonist discrimination between ganglionic and ileal muscarinic receptors. Br J Pharmacol. 1980;71(2):362–364. doi: 10.1111/j.1476-5381.1980.tb10948.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Brunette M. G., Vigneault N., Carriere S. Micropuncture study of magnesium transport along the nephron in the young rat. Am J Physiol. 1974 Oct;227(4):891–896. doi: 10.1152/ajplegacy.1974.227.4.891. [DOI] [PubMed] [Google Scholar]
  22. Cannon J. G., Costall B., Laduron P. M., Leysen J. E., Naylor R. J. Effects of some derivatives of 2-aminotetralin on dopamine-sensitive adenylate cyclase and on the binding of (3H)haloperidol to neuroleptic receptors in the rat striatum. Biochem Pharmacol. 1978 May 15;27(10):1417–1420. doi: 10.1016/0006-2952(78)90094-1. [DOI] [PubMed] [Google Scholar]
  23. Chamness G. C., Asch R. H., Pauerstein C. J. Danazol binding and translocation of steroid receptors. Am J Obstet Gynecol. 1980 Feb 15;136(4):426–429. doi: 10.1016/0002-9378(80)90665-1. [DOI] [PubMed] [Google Scholar]
  24. Chin J. H., Goldstein D. B. Effects of low concentrations of ethanol on the fluidity of spin-labeled erythrocyte and brain membranes. Mol Pharmacol. 1977 May;13(3):435–441. [PubMed] [Google Scholar]
  25. Cinti D. L., Moldeus P., Schenkman J. B. Kinetic parameters of drug-metabolizing enzymes in Ca 2+ -sedimented microsomes from rat liver. Biochem Pharmacol. 1972 Dec 15;21(24):3249–3256. doi: 10.1016/0006-2952(72)90089-5. [DOI] [PubMed] [Google Scholar]
  26. Coombes R. C., Dearnaley D., Humphreys J., Gazet J. C., Ford H. T., Nash A. G., Mashiter K., Powles T. J. Danazol treatment of advanced breast cancer. Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1073–1076. [PubMed] [Google Scholar]
  27. Costall B., De Souza C. X., Naylor R. J. Topographical analysis of the actions of 2(N,N-dipropyl)amino-5,6-dihydroxytetralin to cause biting behaviour and locomotor hyperactivity from the striatum of the guinea-pig. Neuropharmacology. 1980 Jul;19(7):623–631. doi: 10.1016/0028-3908(80)90036-2. [DOI] [PubMed] [Google Scholar]
  28. Costall B., Naylor R. J. Neuroleptic antagonism of dyskinetic phenomena. Eur J Pharmacol. 1975 Sep-Oct;33(2):301–312. doi: 10.1016/0014-2999(75)90174-0. [DOI] [PubMed] [Google Scholar]
  29. Coyle J. T., Yamamura H. I. Neurochemical aspects of the ontogenesis of cholinergic neurons in the rat brain. Brain Res. 1976 Dec 24;118(3):429–440. doi: 10.1016/0006-8993(76)90310-3. [DOI] [PubMed] [Google Scholar]
  30. Crow T. J., Deakin J. F., File S. E., Longden A., Wendlandt S. The locus coeruleus noradrenergic system--evidence against a role in attention, habituation, anxiety and motor activity. Brain Res. 1978 Oct 27;155(2):249–261. doi: 10.1016/0006-8993(78)91021-1. [DOI] [PubMed] [Google Scholar]
  31. Curry S. H., Whelpton R., Nicholson A. N., Wright C. M. Behavioural and pharmacokinetic studies in the monkey (Macaca mulatta) with diazepam, nordiazepam and related 1,4-benzodiazepines. Br J Pharmacol. 1977 Nov;61(3):325–330. doi: 10.1111/j.1476-5381.1977.tb08423.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Devane J., Ryan M. P. The effects of amiloride and triamterene on urinary magnesium excretion in conscious saline-loaded rats. Br J Pharmacol. 1981 Feb;72(2):285–289. doi: 10.1111/j.1476-5381.1981.tb09127.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. El Tahir K. E., Williams K. I. Factors affecting prostacyclin formation by the rat pregnant myometrium. Br J Pharmacol. 1980;71(2):641–649. doi: 10.1111/j.1476-5381.1980.tb10985.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Ely N., Rumble I. R., Sharman D. F. Some observations on the behavioural responses to metoclopramide in the pig and the guinea pig [proceedings]. Br J Pharmacol. 1978 Mar;62(3):392P–393P. [PMC free article] [PubMed] [Google Scholar]
  35. Fain J. N. Biochemical aspects of drug and hormone action on adipose tissue. Pharmacol Rev. 1973 Mar;25(1):67–118. [PubMed] [Google Scholar]
  36. File S. E., Deakin J. F., Longden A., Crow T. J. An investigation of the role of the locus coeruleus in anxiety and agonistic behaviour. Brain Res. 1979 Jun 29;169(3):411–420. doi: 10.1016/0006-8993(79)90393-7. [DOI] [PubMed] [Google Scholar]
  37. File S. E., Hyde J. R., MacLeod N. K. 5,7-dihydroxytryptamine lesions of dorsal and median raphé nuclei and performance in the social interaction test of anxiety and in a home-cage aggression test. J Affect Disord. 1979 Jun;1(2):115–122. doi: 10.1016/0165-0327(79)90030-2. [DOI] [PubMed] [Google Scholar]
  38. File S. E. The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J Neurosci Methods. 1980 Jun;2(3):219–238. doi: 10.1016/0165-0270(80)90012-6. [DOI] [PubMed] [Google Scholar]
  39. Flood J. F., Rosenzweig M. R., Bennett E. L., Orme A. E. Comparison of the effects of anisomycin on memory across six strains of mice. Behav Biol. 1974 Feb;10(2):147–160. doi: 10.1016/s0091-6773(74)91739-8. [DOI] [PubMed] [Google Scholar]
  40. Ford-Hutchinson A. W., Bray M. A., Doig M. V., Shipley M. E., Smith M. J. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 1980 Jul 17;286(5770):264–265. doi: 10.1038/286264a0. [DOI] [PubMed] [Google Scholar]
  41. Fredholm B. B. Local regulation of lipolysis in adipose tissue by fatty acids, prostaglandins and adenosine. Med Biol. 1978 Oct;56(5):249–261. [PubMed] [Google Scholar]
  42. Gardiner P. J., Collier H. O. Specific receptors for prostaglandins in airways. Prostaglandins. 1980 Jun;19(6):819–841. doi: 10.1016/0090-6980(80)90116-1. [DOI] [PubMed] [Google Scholar]
  43. Gardiner P. J., Copas J. L., Elliott R. D., Collier H. O. Tracheobronchial irritancy of inhaled prostaglandins in the conscious cat. Prostaglandins. 1978 Feb;15(2):303–315. doi: 10.1016/0090-6980(78)90170-3. [DOI] [PubMed] [Google Scholar]
  44. Garrett E. R., Hunt C. A. Pharmacokinetics of delta9-tetrahydrocannabinol in dogs. J Pharm Sci. 1977 Mar;66(3):395–407. doi: 10.1002/jps.2600660322. [DOI] [PubMed] [Google Scholar]
  45. Graves P. E., Salhanick H. A. Stereoselective inhibition of aromatase by enantiomers of aminoglutethimide. Endocrinology. 1979 Jul;105(1):52–57. doi: 10.1210/endo-105-1-52. [DOI] [PubMed] [Google Scholar]
  46. Grollman A. P. Inhibitors of protein biosynthesis. II. Mode of action of anisomycin. J Biol Chem. 1967 Jul 10;242(13):3226–3233. [PubMed] [Google Scholar]
  47. Hammer R., Berrie C. P., Birdsall N. J., Burgen A. S., Hulme E. C. Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature. 1980 Jan 3;283(5742):90–92. doi: 10.1038/283090a0. [DOI] [PubMed] [Google Scholar]
  48. Harms H. H., Wardeh G., Mulder A. H. Effect of adenosine on depolarization-induced release of various radiolabelled neurotransmitters from slices of rat corpus striatum. Neuropharmacology. 1979 Jul;18(7):577–580. doi: 10.1016/0028-3908(79)90107-2. [DOI] [PubMed] [Google Scholar]
  49. Harvey D. J., Leuschner J. T., Paton W. D. Measurement of delta 1-tetrahydrocannabinol in plasma to the low picogram range by gas chromatography-mass spectrometry using metastable ion detection. J Chromatogr. 1980 Dec 5;202(1):83–92. doi: 10.1016/s0021-9673(00)80080-1. [DOI] [PubMed] [Google Scholar]
  50. Hawkey C. J., Truelove S. C. Effect of prednisolone on prostaglandin synthesis by rectal mucosa in ulcerative colitis: investigation by laminar flow bioassay and radioimmunoassay. Gut. 1981 Mar;22(3):190–193. doi: 10.1136/gut.22.3.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Hayashi E., Mori M., Yamada S., Kumitomo M. Effects of purine compounds on cholinergic nerves. Specificity of adenosine and related compounds on acetylcholine release in electircally stimulated guinea pig ileum. Eur J Pharmacol. 1978 Apr 1;48(3):297–307. doi: 10.1016/0014-2999(78)90088-2. [DOI] [PubMed] [Google Scholar]
  52. Heel R. C., Brogden R. N., Speight T. M., Avery G. S. Probucol: a review of its pharmacological properties and therapeutic use in patients with hypercholesterolaemia. Drugs. 1978 Jun;15(6):409–428. doi: 10.2165/00003495-197815060-00001. [DOI] [PubMed] [Google Scholar]
  53. Heirwegh K. P., Van de Vijver M., Fevery J. Assay and properties of dititonin-activated bilirubin uridine diphosphate glucuronyltransferase from rat liver. Biochem J. 1972 Sep;129(3):605–618. doi: 10.1042/bj1290605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Hess T., Scholtysik G., Riesen W. The prevention and reversal of digoxin intoxication with specific antibodies. Am Heart J. 1978 Oct;96(4):486–495. doi: 10.1016/0002-8703(78)90160-6. [DOI] [PubMed] [Google Scholar]
  55. Hitchcock M., Kokolis N. A. Arachidonic acid metabolism and modulation of in vitro anaphylaxis by 5,8,11,14-eicosatetraynoic acid and 9a,12a-octadecadiynoic acid. Br J Pharmacol. 1981 Apr;72(4):689–695. doi: 10.1111/j.1476-5381.1981.tb09150.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Hochberg R. B., Hoeven TA vander, Welch M., Lieberman S. A simple and precise assay of the enzymatic conversion of cholesterol into pregnenolone. Biochemistry. 1974 Jan 29;13(3):603–609. doi: 10.1021/bi00700a031. [DOI] [PubMed] [Google Scholar]
  57. ISSELBACHER K. J. Enzymatic mechanisms of hormone metabolism. II. Mechanism of hormonal glucuronide formation. Recent Prog Horm Res. 1956;12:134-46; discussion, 146-51. [PubMed] [Google Scholar]
  58. Illiano G., Cuatrecasas P. Endogenous prostaglandins modulate lipolytic processes in adipose tissue. Nat New Biol. 1971 Nov 17;234(46):72–74. doi: 10.1038/newbio234072a0. [DOI] [PubMed] [Google Scholar]
  59. Jonason K. R., Enloe L. J. Alterations in social behavior following septal and amygdaloid lesions in the rat. J Comp Physiol Psychol. 1971 May;75(2):286–301. doi: 10.1037/h0030808. [DOI] [PubMed] [Google Scholar]
  60. Jones R. L. Definition of prostaglandin-sensitive arterial constrictor systems. Acta Biol Med Ger. 1978;37(5-6):837–844. [PubMed] [Google Scholar]
  61. Kreuz D. S., Axelrod J. Delta-9-tetrahydrocannabinol: localization in body fat. Science. 1973 Jan 26;179(4071):391–393. doi: 10.1126/science.179.4071.391. [DOI] [PubMed] [Google Scholar]
  62. Ladinsky H., Consolo S., Peri G., Garattini S. Acetylcholine, choline and choline acetyltransferase activity in the developing brain of normal and hypothyroid rats. J Neurochem. 1972 Aug;19(8):1947–1952. doi: 10.1111/j.1471-4159.1972.tb01483.x. [DOI] [PubMed] [Google Scholar]
  63. Lenaz G., Curatola G., Mazzanti L., Bertoli E., Pastuszko A. Spin label studies on the effect of anesthetics in synaptic membranes. J Neurochem. 1979 Jun;32(6):1689–1695. doi: 10.1111/j.1471-4159.1979.tb02280.x. [DOI] [PubMed] [Google Scholar]
  64. Li C. K., Mitchelson F. The selective antimuscarinic action of stercuronium. Br J Pharmacol. 1980 Oct;70(2):313–321. doi: 10.1111/j.1476-5381.1980.tb07938.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Lloyd B. L., Smith T. W. Contrasting rates of reversal of digoxin toxicity by digoxin-specific IgG and Fab fragments. Circulation. 1978 Aug;58(2):280–283. doi: 10.1161/01.cir.58.2.280. [DOI] [PubMed] [Google Scholar]
  66. Londos C., Cooper D. M., Schlegel W., Rodbell M. Adenosine analogs inhibit adipocyte adenylate cyclase by a GTP-dependent process: basis for actions of adenosine and methylxanthines on cyclic AMP production and lipolysis. Proc Natl Acad Sci U S A. 1978 Nov;75(11):5362–5366. doi: 10.1073/pnas.75.11.5362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Lu E. J., Brown W. J. The developing caudate nucleus in the euthyroid and hypothyroid rat. J Comp Neurol. 1977 Jan 15;171(2):261–284. doi: 10.1002/cne.901710209. [DOI] [PubMed] [Google Scholar]
  68. Lulich K. M., Mitchell H. W., Sparrow M. P. The cat lung strip as an in vitro preparation of peripheral airways: a comparison of beta-adrenoceptor agonists, autacoids and anaphylactic challenge on the lung strip and trachea. Br J Pharmacol. 1976 Sep;58(1):71–79. doi: 10.1111/j.1476-5381.1976.tb07694.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Maggi A., U'Prichard D. C., Enna S. J. beta-Adrenergic regulation of alpha 2-adrenergic receptors in the central nervous system. Science. 1980 Feb 8;207(4431):645–647. doi: 10.1126/science.6101510. [DOI] [PubMed] [Google Scholar]
  70. McMillen B. A., Warnack W., German D. C., Shore P. A. Effects of chronic desipramine treatment on rat brain noradrenergic responses to alpha-adrenergic drugs. Eur J Pharmacol. 1980 Feb 8;61(3):239–246. doi: 10.1016/0014-2999(80)90126-0. [DOI] [PubMed] [Google Scholar]
  71. Milton A. S., Wendlandt S. Effects on body temperature of prostaglandins of the A, E and F series on injection into the third ventricle of unanaesthetized cats and rabbits. J Physiol. 1971 Oct;218(2):325–336. doi: 10.1113/jphysiol.1971.sp009620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Moncada S., Bunting S., Mullane K., Thorogood P., Vane J. R., Raz A., Needleman P. Imidazole: a selective inhibitor of thromboxane synthetase. Prostaglandins. 1977 Apr;13(4):611–618. doi: 10.1016/0090-6980(77)90232-5. [DOI] [PubMed] [Google Scholar]
  73. Morrison C. F., Stephenson J. A. The occurrence of tolerance to a central depressant effect of nicotine. Br J Pharmacol. 1972 Sep;46(1):151–156. doi: 10.1111/j.1476-5381.1972.tb06857.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Myant N. B., Lewis B. Estimation of the rate of breakdown of cholesterol in man by measurement of 14CO-2 excretion after intravenous [26-14C]cholesterol. Clin Sci. 1966 Feb;30(1):117–127. [PubMed] [Google Scholar]
  75. Müller-Oerlinghausen B., Hasselblatt A., Jahns R. Impaired hepatic synthesis of glucuronic acid conjugates in diabetic rats. Life Sci. 1967 Jul 15;6(14):1529–1533. doi: 10.1016/0024-3205(67)90332-3. [DOI] [PubMed] [Google Scholar]
  76. Nezhat C., Asch R. H., Greenblatt R. B. Danazol for benign breast disease. Am J Obstet Gynecol. 1980 Jul 1;137(5):604–607. doi: 10.1016/0002-9378(80)90704-8. [DOI] [PubMed] [Google Scholar]
  77. Nies A. S., Wilkinson G. R., Rush B. D., Strother J. R., McDevitt D. G. Effects of alteration of hepatic microsomal enzyme activity on liver blood flow in the rat. Biochem Pharmacol. 1976 Sep 1;25(17):1991–1993. doi: 10.1016/0006-2952(76)90055-1. [DOI] [PubMed] [Google Scholar]
  78. Ochs H. R., Vatner S. F., Smith T. W. Reversal of inotropic effects of digoxin by specific antibodies and their Fab fragments in the conscious dog. J Pharmacol Exp Ther. 1978 Oct;207(1):64–71. [PubMed] [Google Scholar]
  79. Ohlsson A., Lindgren J. E., Wahlen A., Agurell S., Hollister L. E., Gillespie H. K. Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin Pharmacol Ther. 1980 Sep;28(3):409–416. doi: 10.1038/clpt.1980.181. [DOI] [PubMed] [Google Scholar]
  80. Ohnhaus E. E., Thorgeirsson S. S., Davies D. S., Breckenridge A. Changes in liver blood flow during enzyme induction. Biochem Pharmacol. 1971 Oct;20(10):2561–2570. doi: 10.1016/0006-2952(71)90164-x. [DOI] [PubMed] [Google Scholar]
  81. Orehek J., Douglas J. S., Bouhuys A. Contractile responses of the guinea-pig trachea in vitro: modification by prostaglandin synthesis-inhibiting drugs. J Pharmacol Exp Ther. 1975 Sep;194(3):554–564. [PubMed] [Google Scholar]
  82. Otani G., Abou-El-Makarem M. M., Bock K. W. UDP-glucuronyltransferase in perfused rat liver and in microsomes - III. Effects of galactosamine and carbon tetrachloride on the glucuronidation of 1-naphthol and bilirubin. Biochem Pharmacol. 1976 Jun 1;25(11):1293–1297. doi: 10.1016/0006-2952(76)90092-7. [DOI] [PubMed] [Google Scholar]
  83. Parratt J. R. Myocardial and circulatory effects of E. coli endotoxin; modification of responses to catecholamines. Br J Pharmacol. 1973 Jan;47(1):12–25. doi: 10.1111/j.1476-5381.1973.tb08154.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Parratt J. R., Sturgess R. M. The possible roles of histamine, 5-hydroxytryptamine and prostaglandin F2alpha as mediators of the acute pulmonary effects of endotoxin. Br J Pharmacol. 1977 Jun;60(2):209–219. doi: 10.1111/j.1476-5381.1977.tb07743.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Patrono C., Ciabattoni G., Pinca E., Pugliese F., Castrucci G., De Salvo A., Satta M. A., Peskar B. A. Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. Thromb Res. 1980 Feb 1;17(3-4):317–327. doi: 10.1016/0049-3848(80)90066-3. [DOI] [PubMed] [Google Scholar]
  86. Peck M. J., Williams T. J., Lewis G. P. Prostacyclin (PGI2) potentiates bradykinin-induced plasma exudation in rabbit skin [proceedings]. Br J Pharmacol. 1978 Mar;62(3):464P–465P. [PMC free article] [PubMed] [Google Scholar]
  87. Peters T. G., Lewis J. D., Wilkinson E. J., Fuhrman T. M. Danazol therapy in hormone-sensitive mammary carcinoma. Cancer. 1977 Dec;40(6):2797–2800. doi: 10.1002/1097-0142(197712)40:6<2797::aid-cncr2820400607>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  88. Pollitt E., Leibel R. L. Iron deficiency and behavior. J Pediatr. 1976 Mar;88(3):372–381. doi: 10.1016/s0022-3476(76)80250-8. [DOI] [PubMed] [Google Scholar]
  89. Potts G. O., Schane H. P., Edelson J. Pharmacology and pharmacokinetics of danazol. Drugs. 1980 May;19(5):321–330. doi: 10.2165/00003495-198019050-00001. [DOI] [PubMed] [Google Scholar]
  90. Pritchard J. F., Schneck D. W., Hayes A. H., Jr Determination of propranolol and six metabolites in human urine by high-pressure liquid chromatography. J Chromatogr. 1979 Jan 1;162(1):47–58. doi: 10.1016/s0378-4347(00)82062-9. [DOI] [PubMed] [Google Scholar]
  91. Rao G. S., Haueter G., Rao M. L., Breuer H. An improved assay for steroid glucuronyltransferase in rat liver microsomes. Anal Biochem. 1976 Jul;74(1):35–40. doi: 10.1016/0003-2697(76)90307-9. [DOI] [PubMed] [Google Scholar]
  92. Rodriguez Boulan E., Sabatini D. D. Asymmetric budding of viruses in epithelial monlayers: a model system for study of epithelial polarity. Proc Natl Acad Sci U S A. 1978 Oct;75(10):5071–5075. doi: 10.1073/pnas.75.10.5071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Rosi D., Neumann H. C., Christiansen R. G., Schane H. P., Potts G. O. Isolation, synthesis, and biological activity of five metabolites of danazol. J Med Chem. 1977 Mar;20(3):349–352. doi: 10.1021/jm00213a007. [DOI] [PubMed] [Google Scholar]
  94. Rothman J. E., Fine R. E. Coated vesicles transport newly synthesized membrane glycoproteins from endoplasmic reticulum to plasma membrane in two successive stages. Proc Natl Acad Sci U S A. 1980 Feb;77(2):780–784. doi: 10.1073/pnas.77.2.780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Rowland M., Benet L. Z., Graham G. G. Clearance concepts in pharmacokinetics. J Pharmacokinet Biopharm. 1973 Apr;1(2):123–136. doi: 10.1007/BF01059626. [DOI] [PubMed] [Google Scholar]
  96. Ruffolo R. R., Jr, Waddell J. E., Yaden E. L. Receptor interactions of imidazolines. IV. Structural requirements for alpha adrenergic receptor occupation and receptor activation by clonidine and a series of structural analogs in rat aorta. J Pharmacol Exp Ther. 1980 May;213(2):267–272. [PubMed] [Google Scholar]
  97. Ruwe W. D., Myers R. D. Fever produced by intrahypothalamic pyrogen: effect of protein synthesis inhibition by anisomycin. Brain Res Bull. 1979 Nov-Dec;4(6):741–745. doi: 10.1016/0361-9230(79)90007-8. [DOI] [PubMed] [Google Scholar]
  98. Santen R. J., Veldhuis J., Samojlik E., Lipton A., Harvey H., Wells S. A. Mechanism of action of aminoglutethimide in breast cancer. Lancet. 1979 Jan 6;1(8106):44–45. doi: 10.1016/s0140-6736(79)90484-7. [DOI] [PubMed] [Google Scholar]
  99. Saxena P. R., Bonta I. L. Mechanism of selective cardiac vagolytic action of pancuronium bromide. Specific blockade of cardiac muscarinic receptors. Eur J Pharmacol. 1970;11(3):332–341. doi: 10.1016/0014-2999(70)90009-9. [DOI] [PubMed] [Google Scholar]
  100. Schimmel R. J., McMahon K. K., Serio R. Interactions between alpha-adrenergic agents, prostaglandin E1, nicotinic acid, and adenosine in regulation of lipolysis in hamsters epididymal adipocytes. Mol Pharmacol. 1981 Mar;19(2):248–255. [PubMed] [Google Scholar]
  101. Schriefers H., Ghraf R., Pohl F. Biosynthese von Steroidglucoronidendurch Rattenlebermikrosomen. Zur Frage des Verhaltens der UDP-Glucuronyl-Transferase Aktivität unter Nahrungsentzug und im Alloxandiabetes. Hoppe Seylers Z Physiol Chem. 1966;344(1):25–33. [PubMed] [Google Scholar]
  102. Schwabe U., Ebert R., Erbler H. C. Adenosine release from isolated fat cells and its significance for the effects of hormones on cyclic 3',5'-AMP levels and lipolysis. Naunyn Schmiedebergs Arch Pharmacol. 1973;276(2):133–148. doi: 10.1007/BF00501186. [DOI] [PubMed] [Google Scholar]
  103. Setler P. E., Sarau H. M., Zirkle C. L., Saunders H. L. The central effects of a novel dopamine agonist. Eur J Pharmacol. 1978 Aug 15;50(4):419–430. doi: 10.1016/0014-2999(78)90148-6. [DOI] [PubMed] [Google Scholar]
  104. Smith M. J., Ford-Hutchinson A. W., Bray M. A. Leukotriene B: a potential mediator of inflammation. J Pharm Pharmacol. 1980 Jul;32(7):517–518. doi: 10.1111/j.2042-7158.1980.tb12985.x. [DOI] [PubMed] [Google Scholar]
  105. Smith T. W., Haber E., Yeatman L., Butler V. P., Jr Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies. N Engl J Med. 1976 Apr 8;294(15):797–800. doi: 10.1056/NEJM197604082941501. [DOI] [PubMed] [Google Scholar]
  106. Sorimachi M., Kataoka K. High affinity choline uptake: an early index of cholinergic innervation in rat brain. Brain Res. 1975 Aug 29;94(2):325–336. doi: 10.1016/0006-8993(75)90065-7. [DOI] [PubMed] [Google Scholar]
  107. Stille G., Lauener H., Eichenberger E. The pharmacology of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine (clozapine). Farmaco Prat. 1971 Oct;26(10):603–625. [PubMed] [Google Scholar]
  108. Stock M. J. An automatic, closed-circuit oxygen consumption apparatus for small animals. J Appl Physiol. 1975 Nov;39(5):849–850. doi: 10.1152/jappl.1975.39.5.849. [DOI] [PubMed] [Google Scholar]
  109. Stolerman I. P., Fink R., Jarvik M. E. Acute and chronic tolerance to nicotine measured by activity in rats. Psychopharmacologia. 1973 Jun 29;30(4):329–342. doi: 10.1007/BF00429192. [DOI] [PubMed] [Google Scholar]
  110. Sugden R. F. The action of indoramin and other compounds on the uptake of neurotransmitters into rat cortical slices. Br J Pharmacol. 1974 Jul;51(3):467–469. doi: 10.1111/j.1476-5381.1974.tb10687.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Sugrue M. F. Effects of acutely and chronically administered antidepressants on the clonidine-induced decrease in rat brain 3-methoxy-4-hydroxyphenylethylene-glycol sulphate content. Life Sci. 1981 Jan 26;28(4):377–384. doi: 10.1016/0024-3205(81)90082-5. [DOI] [PubMed] [Google Scholar]
  112. Sugrue M. F. The inability of chronic mianserin to block central alpha 2-adrenoceptors. Eur J Pharmacol. 1980 Dec 5;68(3):377–380. doi: 10.1016/0014-2999(80)90537-3. [DOI] [PubMed] [Google Scholar]
  113. Sweatman W. J., Collier H. O. Effects of prostaglandins on human bronchial muscle. Nature. 1968 Jan 6;217(5123):69–69. doi: 10.1038/217069a0. [DOI] [PubMed] [Google Scholar]
  114. Tai H. H., Yuan B. On the inhibitory potency of imidazole and its derivatives on thromboxane synthetase. Biochem Biophys Res Commun. 1978 Jan 13;80(1):236–242. doi: 10.1016/0006-291x(78)91128-2. [DOI] [PubMed] [Google Scholar]
  115. Ungerstedt U. Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand Suppl. 1971;367:1–48. doi: 10.1111/j.1365-201x.1971.tb10998.x. [DOI] [PubMed] [Google Scholar]
  116. Vizi E. S., Knoll J. The inhibitory effect of adenosine and related nucleotides on the release of acetylcholine. Neuroscience. 1976;1(5):391–398. doi: 10.1016/0306-4522(76)90132-9. [DOI] [PubMed] [Google Scholar]
  117. Wedmore C. V., Williams T. J. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature. 1981 Feb 19;289(5799):646–650. doi: 10.1038/289646a0. [DOI] [PubMed] [Google Scholar]
  118. Wen S. F., Evanson R. L., Dirks J. H. Micropuncture study of renal magnesium transport in proximal and distal tubule of the dog. Am J Physiol. 1970 Sep;219(3):570–576. doi: 10.1152/ajplegacy.1970.219.3.570. [DOI] [PubMed] [Google Scholar]
  119. Wiebkin P., Fry J. R., Jones C. A., Lowing R. K., Bridges J. W. Biphenyl metabolism in isolated rat hepatocytes: effect of induction and nature of the conjugates. Biochem Pharmacol. 1978;27(15):1899–1907. doi: 10.1016/0006-2952(78)90003-5. [DOI] [PubMed] [Google Scholar]
  120. Wilkinson G. R., Shand D. G. Commentary: a physiological approach to hepatic drug clearance. Clin Pharmacol Ther. 1975 Oct;18(4):377–390. doi: 10.1002/cpt1975184377. [DOI] [PubMed] [Google Scholar]
  121. Williams K. I., El Tahir K. E. Effects of uterine stimulant drugs on prostacyclin production by the pregnant rat myometrium. I. Oxytocin, bradykinin and PGF2 alpha. Prostaglandins. 1980 Jan;19(1):31–38. doi: 10.1016/0090-6980(80)90151-3. [DOI] [PubMed] [Google Scholar]
  122. Williams T. J., Jose P. J. Mediation of increased vascular permeability after complement activation. Histamine-independent action of rabbit C5a. J Exp Med. 1981 Jan 1;153(1):136–153. doi: 10.1084/jem.153.1.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Williams T. J. Prostaglandin E2, prostaglandin I2 and the vascular changes of inflammation. Br J Pharmacol. 1979 Mar;65(3):517–524. doi: 10.1111/j.1476-5381.1979.tb07860.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Yates M. S., Hiley C. R., Roberts P. J., Back D. J., Crawford F. E. Differential effects of hepatic microsomal enzyme inducing agents on liver blood flow. Biochem Pharmacol. 1978;27(22):2617–2621. doi: 10.1016/0006-2952(78)90336-2. [DOI] [PubMed] [Google Scholar]
  125. Yehuda S., Wurtman R. J. Dopaminergic neurons in the nigro-striatal and mesolimbic pathways: mediation of specific effects of D-amphetamine. Eur J Pharmacol. 1975 Feb;30(2):154–158. doi: 10.1016/0014-2999(75)90094-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES